Sulfatidosis: Clinical Trials

12 trials for Sulfatidosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 unknown, 1 recruiting, 1 terminated. 12 Phase 1, 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 112Completed 7, Unknown 2, Recruiting 1, Terminated 1, Withdrawn 1
Phase 29Completed 5, Unknown 2, Terminated 1, Withdrawn 1

Follow Sulfatidosis: new trials by email Literature Review of Sulfatidosis trials Research Report on Sulfatidosis

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide
Allogeneic T cell progenitors, cultured ex-vivo - Hematological Malignancies
Phase 1 / Phase 2UnknownSmart Immune SAS402023-06-062023-09-25
Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)
Umbilical cord blood transplantation with HSC835 - Inherited Metabolic Disorders IMD
Phase 1 / Phase 2WithdrawnNovartis Pharmaceuticals2017-10-102018-11-28
Autologous Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy and Adrenoleukodystrophy
transduced CD34+ hematopoietic stem cell - Metachromatic Leukodystrophy, Adrenoleukodystrophy
Phase 1 / Phase 2UnknownShenzhen Second People's Hospital502015-01-012022-05-31
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
DUOC-01 - Adrenoleukodystrophy, Batten Disease
Phase 1RecruitingJoanne Kurtzberg, MD402014-09-012026-09-03
Intracerebral Gene Therapy for Children With Early Onset Forms of Metachromatic Leukodystrophy
intracerebral administration of AAVrh.10cuARSA - Metachromatic Leukodystrophy
Phase 1 / Phase 2CompletedInstitut National de la Santé Et de la Recherche Médicale, France52014-06-012026-03-02
An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic Leukodystrophy
HGT-1110 - Metachromatic Leukodystrophy (MLD)
Phase 1 / Phase 2CompletedShire242013-05-232026-04-21
Human Placental-Derived Stem Cell Transplantation
Human Placental Derived Stem Cell - Mucopolysaccharidosis I, Mucopolysaccharidosis VI
Phase 1CompletedNew York Medical College432013-04-012022-10-25
Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD)
Recombinant human arylsulfatase A - Metachromatic Leukodystrophy (MLD)
Phase 1 / Phase 2CompletedShire242012-02-022021-06-14
Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders
hematopoietic stem cell infusion - Hurler Syndrome (MPS I), Hurler-Scheie Syndrome
Phase 1 / Phase 2TerminatedTalaris Therapeutics Inc.32011-04-012023-04-12
Gene Therapy for Metachromatic Leukodystrophy (MLD)
OTL-200 Gene Therapy - Lysosomal Storage Disease, Metachromatic Leukodystrophy
Phase 1 / Phase 2CompletedOrchard Therapeutics202010-04-092025-12-05
Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)
rhASA - Dose Level 1, rhASA - Dose Level 2, rhASA - Dose Level 3 - Metachromatic Leukodystrophy (MLD)
Phase 1CompletedShire132007-01-222021-06-25
Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)
Recombinant human Arylsulfatase A (rhASA) - Late Infantile Metachromatic Leukodystrophy
Phase 1 / Phase 2CompletedShire132007-01-222021-06-14

Narrower conditions

Leukodystrophy, Metachromatic (11)  ·  Adrenoleukodystrophy (4)  ·  Leukodystrophy, Globoid Cell (3)  ·  Mucopolysaccharidosis I (3)  ·  Leukemia, Myeloid, Acute (2)  ·  Mucopolysaccharidosis II (2)  ·  Neuronal Ceroid-Lipofuscinoses (2)  ·  Niemann-Pick Diseases (2)  ·  Sandhoff Disease (2)  ·  Tay-Sachs Disease (2)  ·  alpha-Mannosidosis (2)  ·  Anemia, Aplastic (1)  ·  Anemia, Diamond-Blackfan (1)  ·  Brain Diseases, Metabolic, Inborn (1)  ·  Fucosidosis (1)

Broader conditions

Brain Diseases (12)  ·  Brain Diseases, Metabolic (12)  ·  Central Nervous System Diseases (12)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12)  ·  Genetic Diseases, Inborn (12)  ·  Lipid Metabolism Disorders (12)  ·  Lipid Metabolism, Inborn Errors (12)  ·  Lipidoses (12)  ·  Lysosomal Storage Diseases, Nervous System (12)  ·  Metabolic Diseases (12)  ·  Nervous System Diseases (12)  ·  Nutritional and Metabolic Diseases (12)  ·  Sphingolipidoses (12)  ·  Brain Diseases, Metabolic, Inborn (11)

Interventions

Stem Cell Transplantation (1)

Sponsors

Shire (4)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  Joanne Kurtzberg, MD (1)  ·  New York Medical College (1)  ·  Novartis Pharmaceuticals (1)  ·  Orchard Therapeutics (1)  ·  Shenzhen Second People's Hospital (1)  ·  Smart Immune SAS (1)  ·  Talaris Therapeutics Inc. (1)

Countries

Denmark (4)  ·  France (4)  ·  United States (3)  ·  Australia (2)  ·  Germany (2)  ·  Japan (2)  ·  Brazil (1)  ·  China (1)  ·  Czechia (1)  ·  Italy (1)

Top investigators

Caroline Sevin, MD-PhD (1)  ·  GuangFu Chen, M.D.,Ph.D (1)  ·  Hua Jiang, M.D,Ph.D (1)  ·  Jiacai Zhuo (1)  ·  Joanne Kurtzberg, MD (1)  ·  Michel Zerah, MD, PhD (1)  ·  Mitchell S Cairo, MD (1)  ·  Nathalie Cartier, MD, PhD (1)  ·  Patrick Aubourg, MD-PhD (1)  ·  Qizhou Lian, M.D.,Ph.D. (1)  ·  Suzanne T Ildstad, MD (1)  ·  Thomas Roujeau, MD, PhD (1)

Results publications

PMID 33332761, PMID 11231629, PMID 11399225, PMID 19892975, PMID 23845948, PMID 23966770, PMID 25758611, PMID 26000324, PMID 27289174, PMID 32792226, PMID 35065785, PMID 40267426